Educational & Research Use Only. Not medical advice. Compounds are research-grade and not FDA-approved unless explicitly noted.
04
Section 04 · 12 compounds

Growth Hormone & Regenerative Axis

The hormonal architecture behind cellular renewal, lean mass, and recovery.

Home/ Sections/ Growth Hormone & Regenerative Axis

Growth hormone is the body's master architect of renewal — orchestrating tissue repair, lean mass, and recovery. As secretion declines with age, researchers study GHRH analogs, GH-releasing peptides, and downstream effectors to support this regenerative axis without bypassing it.

Click any peptide below to expand. Each entry covers what it is, what it's being studied to do, why it matters, potential impact, and common research pairings, with quick facts in the sidebar.

191 Amino Acids · FDA Approved For Specific Conditions

HGH is the body's master conductor of growth, repair, and metabolism — a 191-amino-acid peptide hormone produced by the anterior pituitary gland. Recombinant HGH has been used clinically for decades and is FDA-approved for growth hormone deficiency, certain wasting disorders, short stature in children, and adult GH deficiency syndromes. In broader research, it's studied both as exogenous hormone and in relation to endogenous stimulation.

What It's Being Studied To Do

  • Stimulate muscle protein synthesis
  • Increase collagen production in skin and connective tissues
  • Enhance fat metabolism (lipolysis)
  • Improve bone mineral density
  • Accelerate cellular regeneration and wound healing
  • Elevate IGF-1 production in the liver, mediating tissue-building effects
  • Support recovery from physical stress or injury

Why This Matters

Growth hormone pulses are highest during youth and deep sleep, driving repair, strength, and vitality. As levels decline naturally with age — or are suppressed by chronic stress, poor sleep, or metabolic issues — people often notice slower healing, loss of muscle tone, easier fat gain, thinner skin, and reduced resilience. HGH research explores ways to restore appropriate signaling, helping the body reclaim aspects of its original regenerative capacity.

Potential Impact Being Explored

Extensive clinical data (especially in deficiency states) shows improvements in lean muscle mass, fat distribution, skin thickness and elasticity, bone strength, exercise capacity, mood and energy, and overall regenerative markers. Continued interest in quality-of-life benefits, anti-aging pathways, and combination strategies that preserve natural feedback loops.

Common Research Pairings

CJC-1295 + Ipamorelin · natural pulsatile releaseTesamorelin · visceral fat focusPEG-MGF · localized muscle repairMOTS-C / SS-31 · mitochondrial support

83 Amino Acids · Modified for Extended Half-Life

If HGH is the conductor, IGF-1 is the musician — the protein that actually carries out much of the building and repair work in tissues. IGF-1 LR3 is a modified version with an arginine at position 3 and an extended chain that dramatically increases its half-life and reduces binding to inhibitory proteins, making it more potent and longer-lasting in research models.

What It's Being Studied To Do

  • Directly stimulate muscle cell growth (hypertrophy and hyperplasia)
  • Enhance protein synthesis in skeletal muscle and connective tissues
  • Accelerate tissue regeneration after injury or stress
  • Improve recovery from physical training or trauma
  • Promote anabolic (building) signaling pathways
  • Support satellite cell activation — the stem-like cells that repair and grow muscle fibers

Why This Matters

While GH acts as the conductor, IGF-1 carries out the actual building work in muscles, tendons, cartilage, and other tissues. Declining natural IGF-1 levels with age or chronic stress contribute to muscle loss (sarcopenia), slower healing, reduced strength, and fragility. IGF-1 LR3 research explores how strengthening this key downstream signal might help restore the body's natural capacity for tissue maintenance and growth.

Potential Impact Being Explored

Accelerated muscle recovery, increased lean mass markers, enhanced structural repair in tendons and ligaments, improved strength development after mechanical stress, and greater anabolic response overall. Particularly interesting in localized repair studies (e.g., near injury sites).

Common Research Pairings

HGH · full axis effectsPEG-MGF · localized muscle signalingCJC-1295 + Ipamorelin · upstream supportBPC-157 / TB-500 · structural repair

Physiologic Pulsatile Release Pairing

This is one of the most popular research pairings in the GH axis. CJC-1295 without DAC is a 29-amino-acid GHRH analog that stimulates the pituitary to release GH in short bursts. Ipamorelin is a 5-amino-acid selective ghrelin receptor agonist that triggers natural GH release with minimal impact on cortisol or prolactin. Together — and without the DAC modification — they promote a pulsatile pattern that resembles youthful natural secretion.

What It's Being Studied To Do

  • Increase endogenous GH release in natural pulses
  • Elevate IGF-1 levels downstream
  • Improve recovery from exercise or injury
  • Enhance fat metabolism through lipolysis
  • Support lean muscle development and preservation
  • Improve sleep quality (since GH pulses peak at night)

Why This Matters

The body is designed to release GH in rhythmic pulses — mostly during deep sleep — to drive nightly repair, fat burning, and tissue maintenance. Modern life flattens these pulses, leading to slower recovery, muscle loss, stubborn fat, and reduced vitality. This pairing's research focuses on gently restoring those natural rhythms rather than overriding them.

Potential Impact Being Explored

Improved sleep-driven GH pulses, faster post-workout or injury recovery, modest increases in lean mass and strength markers, enhanced fat utilization, better energy and mood, and a more youthful regenerative profile compared to single-compound approaches. The "clean" side-effect profile makes it a favorite in longevity and performance research.

Common Research Pairings

HGH · broader axis coveragePEG-MGF · localized muscle repairTesamorelin · visceral fatMOTS-C / SS-31 · mitochondrial support

Extended-Release Sustained Stimulation

Same pairing — different rhythm. The DAC (Drug Affinity Complex) modification on CJC-1295 binds to albumin, extending the half-life from hours to days. The result is sustained GH stimulation rather than short pulses, leading to more prolonged elevation of GH and IGF-1 levels. Researchers reach for the DAC version when they want steady "background" support rather than mimicking natural rhythms.

What It's Being Studied To Do

  • Sustain increases in GH and IGF-1 production
  • Provide greater overall anabolic signaling
  • Enhance lean mass development
  • Improve fat metabolism and body composition
  • Strengthen recovery capacity from physical or metabolic stress
  • Amplify regenerative effects across tissues (muscle, skin, connective)

Why This Matters

While natural GH release is pulsatile, some research contexts benefit from sustained elevation — overcoming severe deficiency states or maximizing anabolic windows. This pairing investigates how prolonged axis support might restore vitality, strength, and repair capacity in situations where short pulses alone are insufficient, while still working through the body's own production rather than direct hormone replacement.

Potential Impact Being Explored

Higher total GH/IGF-1 exposure, more pronounced lean mass gains, improved fat loss markers, enhanced recovery from intense training or injury, and better overall body composition compared to shorter-acting versions.

Common Research Pairings

PEG-MGF · localized muscle effectsIGF-1 LR3 · downstream amplificationAOD-9604 / MOTS-C · fat focus

5 Amino Acids · Cleanest Side-Effect Profile in Class

Ipamorelin is a small, synthetic 5-amino-acid peptide that acts as a highly selective agonist of the ghrelin receptor (GHS-R1a). Ghrelin is the body's natural "hunger hormone," but Ipamorelin is engineered to stimulate growth hormone release with much greater specificity than older secretagogues — meaning it triggers GH pulses with very little to no increase in cortisol, prolactin, or other stress hormones. It's one of the cleanest GH-releasing peptides in research.

What It's Being Studied To Do

  • Increase natural pulsatile GH release from the pituitary
  • Modestly elevate downstream IGF-1 levels
  • Improve recovery from training and minor injuries
  • Support lean muscle development and preservation
  • Enhance fat metabolism through increased lipolysis
  • Promote better sleep-related GH pulses

Why This Matters

The body is wired to release GH in short, powerful bursts — especially at night — to repair tissues, burn fat, and maintain strength. Many people lose this rhythm due to age, poor sleep, or chronic stress. Ipamorelin research explores a way to gently nudge the pituitary back toward its original pulsing pattern without flooding the body with excess hormones.

Potential Impact Being Explored

Improved sleep quality and nighttime recovery, modest but consistent lean mass support, better fat utilization (especially with diet/exercise), faster bounce-back from workouts or strains, and an overall "youthful" regenerative feel with a very favorable side-effect profile.

Common Research Pairings

CJC-1295 (DAC or No-DAC) · GH pulse synergyTesamorelin · fat focusPEG-MGF · localized repairMOTS-C / AOD-9604 · body composition

44 Amino Acids · FDA Approved (Egrifta)

Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH), modified for stability and potency. It's one of the few peptides in this category with formal FDA approval — for the reduction of excess visceral fat in HIV-associated lipodystrophy — but it's widely studied beyond that specific indication for general metabolic and body-composition research.

What It's Being Studied To Do

  • Stimulate natural endogenous GH release from the pituitary
  • Significantly reduce visceral adipose tissue (the dangerous fat around organs)
  • Improve body composition — less belly fat, better fat-to-muscle ratio
  • Elevate IGF-1 levels
  • Enhance metabolic markers (lipid profiles, insulin sensitivity in some models)
  • Support overall metabolic function while preserving feedback regulation

Why This Matters

Visceral fat is the deep abdominal fat strongly linked to insulin resistance, inflammation, heart disease risk, and metabolic slowdown. Many face this from modern diets and lifestyles. By targeting GH release to preferentially reduce harmful fat while supporting lean tissue, Tesamorelin research aligns with restoring balanced energy distribution.

Potential Impact Being Explored

Meaningful reductions in visceral fat, improvements in waist circumference and body composition, favorable shifts in cholesterol/triglyceride markers, modest lean mass preservation, and better metabolic health indicators — particularly in fat redistribution or age-related metabolic changes.

Common Research Pairings

Ipamorelin · GH pulse synergyAOD-9604 · direct fat signalingMOTS-C · mitochondrial adaptationCJC-1295 · GHRH amplification

29 Amino Acids · Identical to Native GHRH Active Region

Sermorelin is a 29-amino-acid synthetic analog of natural GHRH — the hypothalamic signal that prompts the pituitary to secrete GH in physiologic pulses. It's identical to the active portion of native GHRH and has been used clinically for diagnostic testing of GH deficiency. Among GH secretagogues, it's considered the most conservative, upstream approach.

What It's Being Studied To Do

  • Stimulate natural pulsatile GH release from the pituitary
  • Increase IGF-1 production downstream
  • Support lean muscle maintenance
  • Enhance recovery capacity from training and daily wear
  • Promote fat metabolism
  • Improve sleep-associated GH pulses
  • Aid healthier aging by reinforcing the body's own regulatory axis

Why This Matters

The pituitary-GH system is designed to respond to natural cues like sleep, exercise, and fasting with timed pulses that drive repair and metabolism. As we age or face chronic stress, this responsiveness fades. Sermorelin research focuses on gently reawakening this upstream pathway — helping the body remember and restore its original rhythm of growth and regeneration.

Potential Impact Being Explored

Improved sleep quality and nighttime recovery, modest increases in lean mass and strength markers, better fat utilization, enhanced energy and mood, and support for age-related decline in regenerative capacity — all while maintaining natural feedback loops.

Common Research Pairings

Ipamorelin · dual-pathway GH stimulationMOTS-C · metabolic flexibilityPEG-MGF · targeted muscle repairTesamorelin · visceral fat focus

Hexapeptide · Robust GH + Hunger Stimulation

GHRP-6 is a synthetic hexapeptide (6 amino acids) that strongly binds the ghrelin receptor in the pituitary and hypothalamus. Unlike the more selective Ipamorelin, GHRP-6 closely mimics the full effects of natural ghrelin — meaning it reliably triggers GH release, but also noticeably increases appetite. It's one of the earlier and most widely researched GHRPs.

What It's Being Studied To Do

  • Potently stimulate natural GH pulses from the pituitary
  • Elevate IGF-1 levels
  • Significantly increase appetite via ghrelin pathway activation
  • Support lean muscle development through anabolic signaling
  • Enhance recovery from training or catabolic states
  • Improve fat metabolism when paired with caloric control
  • Show potential benefits in muscle-wasting or undernourished research models

Why This Matters

In situations like muscle loss from illness, aging, or inadequate nutrition, the body's natural drive to eat and rebuild can become blunted. GHRP-6 research explores how amplifying both GH release and appetite signals might help restore a balanced anabolic environment — supporting the design where hunger cues and repair processes work hand-in-hand. For those not seeking the appetite boost, it's typically contrasted with cleaner options like Ipamorelin.

Potential Impact Being Explored

Strong GH/IGF-1 elevation, noticeable appetite increase (helpful in wasting contexts, challenging in fat-loss ones), accelerated recovery and lean mass support in anabolic-focused models, improved nitrogen retention, and enhanced overall regenerative signaling — particularly when food intake is intentionally increased to match the heightened hunger.

Common Research Pairings

CJC-1295 · GH pulse amplificationIGF-1 LR3 · downstream anabolic boostPEG-MGF · localized repairAOD-9604 · fat-metabolism balance

Hexapeptide · Cardioprotective + Neuroprotective Properties

Hexarelin is a synthetic hexapeptide and one of the most potent growth hormone secretagogues in its class. It strongly activates the ghrelin receptor — but unlike older GHRPs, it also exhibits unique cardioprotective and neuroprotective properties in research models, distinguishing it from peers focused purely on muscle and metabolism.

What It's Being Studied To Do

  • Stimulate powerful natural GH pulses
  • Elevate IGF-1 levels
  • Significantly increase appetite
  • Support lean muscle development and recovery
  • Enhance fat metabolism
  • Provide protective effects on heart tissue and neurons in stress or injury models

Why This Matters

In situations of muscle loss, slow recovery, or low GH signaling, the body benefits from strong, natural repair signals. Hexarelin research explores how potent GH stimulation combined with appetite support might help restore strength, vitality, and anabolic balance — with the added bonus of protective effects on critical tissues.

Potential Impact Being Explored

Very strong GH release (often stronger than other GHRPs), noticeable appetite increase (useful in wasting conditions), accelerated recovery, improved lean mass markers, and cardioprotective effects in preclinical models. Considered one of the most powerful GH secretagogues available for research.

Common Research Pairings

CJC-1295 · GH pulse amplificationPEG-MGF · localized muscle repairIGF-1 LR3 · downstream anabolic effectsAOD-9604 · body composition focus

IGF-1 Splice Variant · Localized Muscle Repair

PEG-MGF is a pegylated (extended half-life) version of Mechano Growth Factor, a naturally occurring splice variant of the IGF-1 gene produced locally in muscle tissue in response to mechanical stress, resistance exercise, or injury. The PEG modification makes it more stable and longer-acting for research. It's a downstream, targeted mediator — the signal muscle sends specifically when it's been worked or wounded.

What It's Being Studied To Do

  • Activate satellite cells (muscle stem cells) at sites of mechanical damage or stress
  • Promote localized muscle fiber repair and regeneration
  • Enhance protein synthesis in damaged or exercised muscle tissue
  • Support new muscle cell formation (hypertrophy and hyperplasia locally)
  • Accelerate recovery following resistance training or injury
  • Improve structural adaptation in skeletal muscle without significant systemic spillover

Why This Matters

Muscle doesn't grow or heal uniformly — repair happens most efficiently right where stress or damage occurs. Natural MGF production is a built-in response to exercise or trauma, but it's short-lived. PEG-MGF research explores extending and amplifying this localized "repair call" to help muscles rebuild stronger and faster.

Potential Impact Being Explored

Faster recovery of muscle function after strain or eccentric exercise, increased satellite cell activation and myonuclear addition, enhanced localized hypertrophy, reduced muscle damage markers post-workout, and improved tissue quality in targeted areas. A favorite in sports recovery and localized regeneration studies.

Common Research Pairings

HGH or CJC-1295 + Ipamorelin · systemic GHIGF-1 LR3 · broader anabolic supportBPC-157 / TB-500 · tendon repairKPV · post-workout inflammation

ActRIIB-Fc Decoy Receptor · Removes Muscle Limiters

ACE-031 takes a fundamentally different approach: instead of pushing muscle growth signals harder, it removes the brakes. It's a recombinant fusion protein consisting of the extracellular domain of the activin type IIB receptor (ActRIIB) fused to the Fc portion of human IgG. As a soluble "decoy receptor," it binds and neutralizes myostatin (GDF-8) and other TGF-β family members that normally limit muscle growth.

What It's Being Studied To Do

  • Significantly increase skeletal muscle mass and cross-sectional area
  • Enhance muscle strength and functional performance in atrophy or aging models
  • Preserve lean body mass during catabolic states (disuse, cachexia, glucocorticoid exposure)
  • Improve muscle fiber size (hypertrophy) and potential hyperplasia
  • Support bone mineral density and metabolic markers (secondary effects from increased muscle)
  • Reduce fat mass in some obesity/wasting combination studies

Why This Matters

Muscle loss from aging, illness, inactivity, or metabolic stress robs people of strength, mobility, independence, and metabolic health. Muscle is one of the body's largest glucose sinks and hormone regulators. ACE-031 research explores removing the natural limiters on muscle growth, helping restore the robust physique and resilience the body was originally designed with — especially against the accelerated decline of modern lifestyles.

Potential Impact Being Explored

Rapid, dose-dependent increases in lean muscle mass (up to 5–10% in short periods in some models), significant strength gains and functional improvements, preservation of muscle during catabolic challenges, favorable shifts in body composition, and potential benefits for bone health. Note: development paused in some trials due to reversible side effects (e.g., nosebleeds from vascular changes), but interest continues in refined myostatin inhibitors.

Common Research Pairings

HGH or IGF-1 LR3 · amplified anabolic signalingCJC-1295 + Ipamorelin · synergistic preservationPEG-MGF · localized + systemic synergyAOD-9604 / Retatrutide · body composition

Recombinant Glycoprotein · Aggressive Hypertrophy Signaling

FST344 is a recombinant form of follistatin, a naturally occurring glycoprotein that acts as a potent myostatin inhibitor. It functions as a "decoy" — binding and neutralizing the proteins that normally cap muscle growth. In preclinical research, it's one of the most powerful anabolic tools studied for hypertrophy, often producing dramatic effects.

What It's Being Studied To Do

  • Dramatically increase skeletal muscle mass and strength by removing myostatin's natural brake
  • Promote muscle fiber hypertrophy and potential hyperplasia
  • Preserve lean mass during catabolic states
  • Improve functional performance
  • Support bone density as a secondary benefit of increased muscle

Why This Matters

Myostatin is the body's built-in limiter on muscle size — designed to prevent excessive growth. In aging, illness, or inactivity, this limit contributes to sarcopenia and frailty. FST344 research explores safely removing this biological brake to help restore stronger, more resilient muscle tissue.

Potential Impact Being Explored

Preclinical studies consistently show dramatic increases in muscle size and strength (often 2–3x normal growth in animal models), improved functional performance, muscle preservation during wasting conditions, and favorable body composition changes. Frequently described as one of the most potent anabolic approaches in muscle research.

Common Research Pairings

ACE-031 · dual myostatin pathway targetingHGH or IGF-1 LR3 · synergistic growth signalingPEG-MGF · localized muscle repairAOD-9604 · fat loss balance
← 03 · Inflammation & Immune-Modulated Repair 05 · Neurological Repair & Neurocognitive Support →